The landscape of dementia analysis has advanced radically with the arrival of refined biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent checks that will detect Alzheimer's pathology yrs prior to signs or symptoms arise. Although these technological innovations represent impressive development in understanding neurodegenerative